So-Young (SY) Q2 2026 earnings review
Offline Pivot Reaches Critical Mass as Losses Narrow
So-Young's radical transformation from a capital-light online aesthetic platform into a capital-intensive physical clinic chain is bearing fruit. Total revenue hit a record RMB 505.2 million, driven entirely by the aesthetic center business, which surged 129.5% YoY. More importantly, the economies of scale are starting to manifest: despite aggressive expansion to 65 clinics, GAAP net loss reversed its widening trend, narrowing to RMB 22.7 million from RMB 36.0 million a year ago. The legacy platform business continues its terminal decline, but the physical center unit economics (47 of 65 centers are now profitable) prove the new model is viable.
🐂 Bull Case
Out of 65 operational centers, 47 achieved profitability and 51 generated positive operating cash flow. Same-store sales growth accelerated to 52%, proving the company can drive utilization at existing locations, not just buy revenue through new store openings.
While total revenues grew 33.4%, total operating expenses only grew 10.4%. R&D expenses actually declined 21.7% due to staff efficiency improvements, helping narrow the net loss by 37% YoY.
🐻 Bear Case
The shift from software (Information Services) to physical clinics (Aesthetic Centers) means structurally lower gross margins. Cost of revenues jumped 53% YoY—vastly outpacing the 33.4% top-line growth.
Information and reservation services plunged 35% YoY. The online platform continues to bleed medical service providers. If the legacy business falls to zero faster than the physical clinics scale, consolidated profitability will be delayed.
⚖️ Verdict: 🟢
Bullish. The execution on the physical clinic rollout is exceptional. Management is successfully balancing rapid unit expansion with improving center-level profitability. The worst of the cash burn appears to be in the rear-view mirror.
Key Themes
Aesthetic Centers Expansion Executing Flawlessly
The primary growth engine is firing on all cylinders. The company expanded its physical footprint to 65 clinics across 18 major cities (up from 54 in Q1 26 and 29 a year ago). Verified treatment visits skyrocketed 145% to 165,200. Crucially, 72% of these centers (47 of 65) are already profitable, validating management's 'Sam's Club of medical aesthetics' standardized model.
Legacy Business Drag Persists
The legacy Information and reservation services segment decelerated sharply, falling 35.0% YoY to RMB 87.9 million. Management attributed this to a decrease in medical service providers subscribing to the platform. Other services (insurance brokerage) also plummeted 48.2%. The physical centers must now carry the entire weight of the company's top-line growth.
Core Member Stickiness & LTV
So-Young's tiered membership strategy is successfully securing recurring revenue. The number of core members grew by 15,000 sequentially (+24%). These high-value members contributed over 80% of aesthetic treatment services revenues and displayed a massive quarterly repurchase rate of nearly 70%. This lowers customer acquisition costs (CAC) and drives the 52% same-store sales growth.
Cost Mix Shifts & Cash Burn
While net loss narrowed, the balance sheet reflects the capital intensity of the '1,000 centers' ambition. Total cash and investments dropped from RMB 936.4M at year-end 2025 to RMB 848.2M by June 2026. Furthermore, Cost of Aesthetic Treatment Services spiked 118% YoY. Operating an offline chain requires heavy investments in consumable materials, personnel, and rent, permanently altering the company's margin profile from its software roots.
AI-Powered Operational Efficiency
Management explicitly cited 'deeper AI integration' as a driver for scaling efficiently. This represents an evolution from earlier quarters where 'standardization' was the buzzword. AI is likely being deployed in centralized digital management and initial automated diagnostic consultations, enabling the 21.7% YoY reduction in R&D expenses despite rapid physical expansion.
Other KPIs
Reversing. After peaking at a loss of RMB 108.8M in Q4 2025 and RMB 49.2M in Q1 2026, the Q2 net loss narrowed significantly to RMB 22.7M. This indicates that the new aesthetic centers are generating enough gross profit to start covering the corporate overhead.
Accelerating. Up from 14% in the same quarter of 2025. This is a critical metric for a rapidly expanding retail chain. It proves that older cohorts of clinics are continuously increasing their capacity utilization and patient throughput, rather than flatlining after an initial opening surge.
Stable relative to revenue. S&M increased 16.8% YoY, primarily due to higher payroll costs at the branded centers and user acquisition. However, since total revenues grew 33.4%, S&M expenses as a percentage of revenue actually declined, showing improved marketing efficiency.
Guidance
Decelerating growth rate, but strong absolute performance. The midpoint (RMB 357M) represents a YoY increase of ~94.5%. While this is a deceleration from Q2's 129.5% YoY growth, it represents an RMB ~25M sequential increase from Q2 2026, indicating steady physical footprint expansion.
Key Questions
Legacy Platform Floor
Information and reservation services revenue fell another 35% this quarter. Do you anticipate this segment will eventually zero out as you transition to a fully self-operated model, or is there a natural stabilization point for the online marketplace?
Franchise Model Viability
You currently operate 63 direct centers and only 2 franchised centers. To reach your long-term goal of 1,000 centers, how heavily will you rely on franchising, and what are the margin implications of a franchise vs. direct-operated model?
Cash Runway for Expansion
Total cash and short-term investments have decreased by roughly RMB 88 million in the first half of 2026. Given the capital intensity of opening new centers, will internal cash flows be sufficient to fund the rollout, or will you need to tap external financing within the next 12-18 months?